Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00700063 · ClinicalTrials.gov registry record · Phase 2
A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
A Phase 2 study, sponsored by Peplin.
- Completed
- Registry status
- Phase 2
- Development phase
- 265
- Enrollment target
NCT00700063 is a Phase 2 study that has completed, run by Peplin. The registered enrollment target is 265 participants.
The verdict
NCT00700063, a Phase 2 study, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 265 participants
- Enrollment target
Study Summary
This Phase IIb study is designed to assess the safety and efficacy of 0.005%, 0.01% and 0.015% PEP005 Topical Gel when applied to an area of skin, containing 4-8 AK lesions on the face or scalp.
Interventions
- DRUG Vehicle gel
- DRUG PEP005 Topical Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00700063
The ClinicalTrials.gov registry entry for NCT00700063 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 265 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Peplin, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle gel is the first listed.
NCT00700063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00700063 about?
NCT00700063 is a clinical study titled "A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)". This Phase IIb study is designed to assess the safety and efficacy of 0.005%, 0.01% and 0.015% PEP005 Topical Gel when applied to an area of skin, containing 4-8 AK lesions on the face or scalp.
What is the current status of trial NCT00700063?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 265 participants. The study started on 2008-06. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00700063?
The interventions under investigation include: Vehicle gel (DRUG), PEP005 Topical Gel (DRUG).
Who is sponsoring clinical trial NCT00700063?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.